Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$2.1 - $3.36 $194,676 - $311,482
92,703 Added 18.07%
605,671 $1.4 Million
Q4 2022

Feb 07, 2023

SELL
$2.05 - $3.47 $1.05 Million - $1.78 Million
-512,968 Reduced 50.0%
512,968 $1.29 Million
Q3 2022

Nov 14, 2022

BUY
$0.63 - $5.47 $323,169 - $2.81 Million
512,968 Added 100.0%
1,025,936 $2.98 Million
Q3 2021

Nov 12, 2021

BUY
$9.94 - $12.77 $5.1 Million - $6.55 Million
512,968 New
512,968 $6.36 Million

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Gagnon Advisors, LLC Portfolio

Follow Gagnon Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Advisors, LLC with notifications on news.